NON-INVASIVE CANCER SOLUTIONS
Safe | Accurate | Easy on the Patient
EXECUTIVE SUMMARY
| What | Analysis of Cell Free DNA (cfDNA) and Circulating Tumor Associated Cells (C-TACs) to check treatment response / recurrence. |
| For Whom | Patients who have been treated and are required to be monitored for response to treatment or for recurrence. |
| Why | Radiological imaging is not always able to detect changes in the tumor at the molecular level or early signs of recurrence. Additionally, there are inherent risks associated with radiological imaging. |
| How | cfDNA from the patient’s peripheral blood is analysed for qualitative and quantitative changes in targeted genes. |
| Sample Type | 22 ml peripheral blood (5-6 hours fasting) as per protocol. |
| Turn Around Time | 5 days |
CONTACT US
Please contact us for more details.